{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:45:09Z","timestamp":1792183509377,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010230","name":"Queensland Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.euo.2025.02.004","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T17:04:01Z","timestamp":1744477441000},"page":"1227-1236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["An Online Treatment Decision Aid for Men with Low-risk Prostate Cancer Eligible for Active Surveillance and Their Partners Increases the Uptake of Active Surveillance: The Navigate Randomised Controlled Trial"],"prefix":"10.1016","volume":"8","author":[{"given":"Penelope","family":"Schofield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Frydenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa G.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Alexander (\u2019Frank\u2019)","family":"Gardiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan G.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Yaxley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Lawrentschuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Millar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Grummet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Juraskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.02.004_b0005","unstructured":"World Health Organization. Cancer. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer."},{"key":"10.1016\/j.euo.2025.02.004_b0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00345-021-03622-8","article-title":"Active surveillance for prostate cancer: selection criteria, guidelines, and outcomes","volume":"40","author":"Walker","year":"2022","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2025.02.004_b0015","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2025.02.004_b0020","article-title":"Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study","volume":"371","author":"Mazariego","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.euo.2025.02.004_b0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142024 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"issue":"Suppl 1","key":"10.1016\/j.euo.2025.02.004_b0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/bju.15698","article-title":"Large variation in conservative management of low-risk prostate cancer in Australia and New Zealand","volume":"130","author":"Ong","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.02.004_b0035","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1158\/1055-9965.EPI-15-1079","article-title":"Treatment preferences for active surveillance versus active treatment among men with low-risk prostate cancer","volume":"25","author":"Taylor","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euo.2025.02.004_b0040","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.eururo.2016.03.048","article-title":"Long-term results of active surveillance in the G\u00f6teborg randomized, population-based prostate cancer screening trial","volume":"70","author":"Godtman","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.02.004_b0045","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1002\/cncr.21822","article-title":"Why do men choose one treatment over another? A review of patient decision making for localized prostate cancer","volume":"106","author":"Zeliadt","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2025.02.004_b0050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/jncimonographs\/lgs023","article-title":"Improving the communication of benefits and harms of treatment strategies: decision AIDS for localized prostate cancer treatment decisions","volume":"2012","author":"Hoffman","year":"2012","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.euo.2025.02.004_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00345-020-03523-2","article-title":"Overdiagnosis in urologic cancer","volume":"40","author":"Klotz","year":"2022","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2025.02.004_b0060","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00345-016-1914-3","article-title":"Prostate cancer progression and mortality: a review of diet and lifestyle factors","volume":"35","author":"Peisch","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2025.02.004_b0065","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/pon.3576","article-title":"'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option","volume":"23","author":"O'Callaghan","year":"2014","journal-title":"Psychooncology"},{"key":"10.1016\/j.euo.2025.02.004_b0070","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"4","author":"Stacey","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.euo.2025.02.004_b0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c5146","article-title":"Implementing shared decision making in the NHS","volume":"341","author":"Elwyn","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.euo.2025.02.004_b0080","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/0272989X11434601","article-title":"The impact of explicit values clarification exercises in a patient decision aid emerges after the decision is actually made: evidence from a randomized controlled trial","volume":"32","author":"Feldman-Stewart","year":"2012","journal-title":"Med Decis Making"},{"key":"10.1016\/j.euo.2025.02.004_b0085","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1464-410X.2012.11402.x","article-title":"Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid","volume":"111","author":"van Tol-Geerdink","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.02.004_b0090","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.urolonc.2011.10.004","article-title":"The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trial","volume":"31","author":"Berry","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.02.004_b0095","first-page":"239","article-title":"Decision aids for localized prostate cancer treatment choice: systematic review and meta-analysis","volume":"65","author":"Violette","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2025.02.004_b0100","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1186\/s12885-019-5649-6","article-title":"Coverage of cancer services in Australia and providers' views on service gaps: findings from a national cross-sectional survey","volume":"19","author":"Hunter","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.euo.2025.02.004_b0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/bco2.279","article-title":"Co\u2010designing an online treatment decision aid for men with low\u2010risk prostate cancer: navigate","volume":"5","author":"Schofield","year":"2024","journal-title":"BJUI Compass"},{"key":"10.1016\/j.euo.2025.02.004_b0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13063-020-04986-9","article-title":"Navigate: a study protocol for a randomised controlled trial of an online treatment decision aid for men with low-risk prostate cancer and their partners","volume":"22","author":"Schofield","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.euo.2025.02.004_b0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1467-9450.2009.00739.x","article-title":"Creating coherence in real-life decision processes: reasons, differentiation and consolidation","volume":"51","author":"Svenson","year":"2010","journal-title":"Scand J Psychol"},{"key":"10.1016\/j.euo.2025.02.004_b0120","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/ans.14722","article-title":"Patterns of care and outcomes for men diagnosed with prostate cancer in Victoria: an update","volume":"88","author":"Wang","year":"2018","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.euo.2025.02.004_b0125","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/pon.6094","article-title":"Examining the effectiveness and implementation of patient treatment decision-aid tools for men with localised prostate cancer: a systematic review","volume":"32","author":"Todio","year":"2023","journal-title":"Psychooncology"},{"key":"10.1016\/j.euo.2025.02.004_b0130","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1007\/s00345-021-03782-7","article-title":"Differences in treatment choices between prostate cancer patients using a decision aid and patients receiving care as usual: results from a randomized controlled trial","volume":"39","author":"Lamers","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2025.02.004_b0135","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1200\/JCO.18.01091","article-title":"Patient-centered preference assessment to improve satisfaction with care among patients with localized prostate cancer: a randomized controlled trial","volume":"37","author":"Jayadevappa","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2025.02.004_b0140","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.eururo.2021.08.001","article-title":"Clinical impact of the predict prostate risk communication tool in men newly diagnosed with nonmetastatic prostate cancer: a multicentre randomised controlled trial","volume":"80","author":"Thurtle","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.02.004_b0145","article-title":"Men's help-seeking in the first year after diagnosis of localised prostate cancer","volume":"26","author":"Hyde","year":"2017","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.euo.2025.02.004_b0150","unstructured":"Australia Government Department of Health. Medical oncology: 2016 factsheet. https:\/\/hwd.health.gov.au\/resources\/publications\/factsheet-mdcl-medical-oncology-2016.pdf."}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125000409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125000409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T17:33:38Z","timestamp":1766511218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125000409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2588931125000409"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.02.004","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Online Treatment Decision Aid for Men with Low-risk Prostate Cancer Eligible for Active Surveillance and Their Partners Increases the Uptake of Active Surveillance: The Navigate Randomised Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}